Skip to content
★ Sign in to follow
Total declarations
51
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (27 ops.)
€5.7M

Latest filing published 06 Jun 2019 for Biomarin Pharmaceutical INC.

Filing timeline

BuySale
Alan Lewis

Insider track record

Disclosed buys
0
Disclosed sells
27
Signal history

Alan Lewis: trading record in brief

Alan Lewis is a declared insider of Biomarin Pharmaceutical Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 10 August 2007 to 4 June 2019, the count stands at 51 filings.

Sales make up the whole of the open-market record (27 sales, €5.7M). Other entries cover 14 share grants and 10 option exercises.

Most recently, on 6 June 2019, the filings show a share grant in Biomarin Pharmaceutical Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Alan Lewis

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations50 total

25 of 50 declarations